Updated
Presented by
With Daniel Lippman
PHARMACEUTICAL COALITION HITS PINGREE, GOLDEN IN ESCALATING E-LABELING FIGHT: A coalition of drugmakers announced a new ad buy today as the lobbying battle about an obscure FDA spending rider moves to the House floor. The
Alliance to Modernize Prescribing Information, whose members include
AbbVie, AmerisourceBergen, Johnson & Johnson, Merck, Bristol Myers Squibb, Viatris, Pfizer and
Teva, announced a 30-second ad targeting Maine Democrats
Jared Golden, whom the group accuses of blocking the FDA from allowing pharmacists to opt out of the paper pamphlets of prescribing information. Congressional appropriators have included a rider in every spending bill since 2015 barring the FDA from carrying out a proposed rule to allow prescribing information to be distributed digitally rather than on paper. Back in April, a bipartisan group of House members wrote to Appropriations Chair
Paper industry, drugmakers spar over requirement to print prescribing information
thehill.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehill.com Daily Mail and Mail on Sunday newspapers.
Kelly out at Teneo
politico.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from politico.com Daily Mail and Mail on Sunday newspapers.
Presented by Coalition for Affordable Prescription Drugs
With help from Erin Banco.
On Tap NIH makes moves on Covid-19 therapy research. Medicaid rebate change nested inside relief legislation.
A message from Coalition for Affordable Prescription Drugs:
The Trump Administration’s prescription drug “Rebate Rule” will raise seniors’ premiums by up to 25%, skyrocket government spending, and will not deliver the lower drug costs that patients need. It should be eliminated to protect seniors and taxpayers. Learn more.
It’s Friday, welcome back to Prescription Pulse. Your authors will someday trek to the National Museum of American History to check out Anthony Fauci’s 3-D model of the coronavirus.